Detalles de la búsqueda
1.
Long-acting cabotegravir pharmacokinetics with and without oral lead-in for HIV PrEP.
Antimicrob Agents Chemother;
: e0147523, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38709006
2.
Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials.
Clin Trials;
20(2): 133-144, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36744680
3.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Lancet;
396(10246): 239-254, 2020 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711800
4.
Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016.
Clin Infect Dis;
71(12): 3144-3151, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32097453
5.
Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.
J Infect Dis;
220(11): 1826-1833, 2019 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362305
6.
Gender Parity in Clinical PrEP Trials.
N Engl J Med;
381(26): 2585, 2019 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881150
7.
Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.
J Antimicrob Chemother;
72(6): 1731-1740, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28369415
8.
Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials.
Clin Infect Dis;
62(7): 929-934, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689956
9.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Lancet;
385(9987): 2606-15, 2015 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25890673
10.
Rare emergence of drug resistance in HIV-1 treatment-naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.
HIV Clin Trials;
17(2): 78-87, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26892863
11.
Tenofovir Alafenamide for HIV Preexposure Prophylaxis.
Ann Intern Med;
173(1): 77-78, 2020 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32628874
12.
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.
Ann Intern Med;
159(2): 86-96, 2013 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23685940
13.
Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial.
EClinicalMedicine;
36: 100893, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34041459
14.
Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients.
HIV Clin Trials;
11(1): 28-38, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20400409
15.
Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
Ann Epidemiol;
44: 16-30, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32088073
16.
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate.
Open Forum Infect Dis;
7(1): ofz472, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31950070
17.
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
J Acquir Immune Defic Syndr;
84(3): 323-330, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539288
18.
Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
Ann Epidemiol;
45: 24-31.e3, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336655
19.
Estimation of new HIV diagnosis rates among high-risk, PrEP-eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States.
J Int AIDS Soc;
22(12): e25433, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860171
20.
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
PLoS One;
14(12): e0226276, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826005